NLRP3 and Parkinson disease: Microglial hyperactivation of the NLRP3 inflammasome has been well-documented in various neurodegenerative diseases, including PD (Lee et al., 2019; Wang et al., 2019; Biasizzo and Kopitar-Jerala, 2020; Ahmed et al., 2021).